Conjugated linoleic acid content in breast adipose tissue of breast cancer patients and the risk of metastasis.
The association between the level of conjugated linoleic acid (CLA) in breast adipose tissue at the time of diagnosis and the subsequent development of metastasis was examined in a cohort of 209 patients presenting with an initially localized breast cancer. CLA level in breast adipose tissue was used as a qualitative biomarker of its past dietary intake. Biopsies of adipose tissue were obtained at the time of initial surgery. A CLA-enriched fraction was prepared by high performance liquid chromatography and CLA measured as a percentage of total fatty acids, using capillary gas chromatography. Mean CLA level was low (0.44% of total fatty acids) and the range between patients was narrow (0.19-0.85). With a median follow-up time of 7.5 yr, 45 patients developed metastases. A Cox proportional hazard regression model was used to identify prognostic factors. We did not find any significant association between CLA level in adipose fat and either the prognostic factor (tumor size, nodal status, histoprognostic grade, mitotic index, and estrogen or progesterone receptors) or the risk of metastasis or death. We concluded that CLA are unlikely to be involved in survivorship. However, the hypothesis that a higher intake of CLA might have a protective effect on the risk of metastasis cannot be ruled out from these data, since the level of CLA in breast cancer patients' adipose tissue is likely to be too low and the range of CLA distribution too narrow for any protection to be detectable.
Chajes
Veronique
V
INSERM EMI-U 0211, IFR 120, Tours. Bretonneau, Tours, France.
Lavillonniere
Flore
F
Maillard
Virginie
V
Giraudeau
Bruno
B
Jourdan
Marie-Lise
ML
Sebedio
Jean-Louis
JL
Bougnoux
Philippe
P
D000273:Adipose Tissue / Q000737:chemistry* / Q000378:metabolism; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000032:analysis; D001940:Breast / Q000737:chemistry; D001943:Breast Neoplasms / Q000737:chemistry* / Q000473:pathology*; D002277:Carcinoma / Q000737:chemistry* / Q000473:pathology / Q000556:secondary*; D002851:Chromatography, High Pressure Liquid; D015331:Cohort Studies; D005227:Fatty Acids / Q000032:analysis; D005260:Female; D006801:Humans; D019787:Linoleic Acid / Q000008:administration & dosage / Q000032:analysis*; D008875:Middle Aged; D011379:Prognosis; D016016:Proportional Hazards Models; D012307:Risk Factors; D013997:Time Factors
D015415:Biomarkers; D005227:Fatty Acids; D019787:Linoleic Acid